Sopharma H1 FY26 net profit rises 35.87% to EUR 52.82 million; revenue increases 10.35% to EUR 717.74 million

• Sopharma posted IFRS net profit of EUR 52.82 million for the six months ended June 30, up from EUR 38.87 million.
• Revenue climbed to EUR 717.74 million from EUR 650.39 million, while operating profit rose to EUR 53.47 million from EUR 36.56 million.
• Profit attributable to equity holders increased to EUR 50.84 million from EUR 35.99 million; basic EPS was EUR 0.09 versus EUR 0.21.
• Cash and cash equivalents stood at EUR 24.55 million at June 30, down from EUR 36.65 million at the start of the year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sopharma AD published the original content used to generate this news brief on August 28, 2026, and is solely responsible for the information contained therein.